Facebook
Twitter
LinkedIn
Forward
In this course, Mary Dunn, MSN, RN, NP-C, OCN, will discuss the different treatment options for advanced prostate cancer as well as considerations for management side effects and maximizing a survivor’s quality of life.
|
We will provide an introduction to blood cancers including risk factors, epidemiology, presenting symptoms, g
|
Course DescriptionIn this talk, Kaitlin Morrison, PhD will take you through how to develop and implement a quality management
|
Course DescriptionIn this talk, Kaitlin Morrison, PhD will take to you about the 3 major reasons that protocols requirement amendments and how to avoid them.
|
Chemotherapy-induced neuropathy is a major clinical problem that can lead to persistent issues for cancer survivors and can even limit the use of planned chemotherapy treatme
|
More than ever before, there are rising cases of colon and rectal cancers among young people. Updated recommendations have lowered the age of screening to age 45 from standa
|
Course DescriptionKaitlin Morrison, PhD takes you through a quick 5 tips that will help you and your team successfully manage an IND.
|
Course DescriptionKaitlin Morrison, PhD takes you through all the different players and roles involved in clinical trial activation.
|
Course DescriptionThis talk given by Kaitlin Morrison, PhD takes you through the role of the activation project manager and h
|
Course DescriptionIn this talk, Leila Kiefer, PhD gives a survey of clinical protocol goals and best practices from literature, guidances, and experient
|